246 related articles for article (PubMed ID: 30171003)
1. Probiotic Product Enhances Susceptibility of Mice to Cryptosporidiosis.
Oliveira BCM; Widmer G
Appl Environ Microbiol; 2018 Nov; 84(21):. PubMed ID: 30171003
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of the intestinal microbiota of mice infected with Cryptosporidium parvum.
Ras R; Huynh K; Desoky E; Badawy A; Widmer G
Int J Parasitol; 2015 Jul; 45(8):567-73. PubMed ID: 25913477
[TBL] [Abstract][Full Text] [Related]
3. Deprivation of dietary fiber enhances susceptibility of mice to cryptosporidiosis.
Oliveira BCM; Bresciani KDS; Widmer G
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007411. PubMed ID: 31560681
[TBL] [Abstract][Full Text] [Related]
4. Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells.
VanDussen KL; Funkhouser-Jones LJ; Akey ME; Schaefer DA; Ackman K; Riggs MW; Stappenbeck TS; Sibley LD
mBio; 2020 Dec; 11(6):. PubMed ID: 33323514
[TBL] [Abstract][Full Text] [Related]
5. Effects of Enterococcus faecalis CECT 7121 on Cryptosporidium parvum infection in mice.
Del Coco VF; Sparo MD; Sidoti A; Santín M; Basualdo JA; Córdoba MA
Parasitol Res; 2016 Aug; 115(8):3239-44. PubMed ID: 27193238
[TBL] [Abstract][Full Text] [Related]
6. Case Report: The impact of severe cryptosporidiosis on the gut microbiota of a pediatric patient with CD40L immunodeficiency.
Piazzesi A; Pane S; Russo A; Del Chierico F; Francalanci P; Cotugno N; Rossi P; Locatelli F; Palma P; Putignani L
Front Cell Infect Microbiol; 2023; 13():1281440. PubMed ID: 37965266
[No Abstract] [Full Text] [Related]
7. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
9. Specific increase of Fusobacterium in the faecal microbiota of neonatal calves infected with Cryptosporidium parvum.
Ichikawa-Seki M; Motooka D; Kinami A; Murakoshi F; Takahashi Y; Aita J; Hayashi K; Tashibu A; Nakamura S; Iida T; Horii T; Nishikawa Y
Sci Rep; 2019 Aug; 9(1):12517. PubMed ID: 31467354
[TBL] [Abstract][Full Text] [Related]
10. Cryptosporidium parvum-Infected Neonatal Mice Show Gut Microbiota Remodelling Using High-Throughput Sequencing Analysis: Preliminary Results.
Mammeri M; Chevillot A; Thomas M; Julien C; Auclair E; Pollet T; Polack B; Vallée I; Adjou KT
Acta Parasitol; 2019 Jun; 64(2):268-275. PubMed ID: 30915719
[TBL] [Abstract][Full Text] [Related]
11. Curcumin mitigates Cryptosporidium parvum infection through modulation of gut microbiota and innate immune-related genes in immunosuppressed neonatal mice.
Rahman SU; Zhou K; Zhou S; Sun T; Mi R; Huang Y; Han X; Gong H; Chen Z
Microb Pathog; 2022 Mar; 164():105424. PubMed ID: 35092833
[TBL] [Abstract][Full Text] [Related]
12. Effects of pine bark extract administered to immunosuppressed adult mice infected with Cryptosporidium parvum.
Kim HC; Healey JM
Am J Chin Med; 2001; 29(3-4):469-75. PubMed ID: 11789589
[TBL] [Abstract][Full Text] [Related]
13. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
[TBL] [Abstract][Full Text] [Related]
14. Microbiome diversity is a modifiable virulence factor for cryptosporidiosis.
Hurle GR; Brainard J; Tyler KM
Virulence; 2023 Dec; 14(1):2273004. PubMed ID: 37872759
[No Abstract] [Full Text] [Related]
15. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Adeyemo O
J Infect Dis; 1997 Jan; 175(1):218-21. PubMed ID: 8985225
[TBL] [Abstract][Full Text] [Related]
16. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
[TBL] [Abstract][Full Text] [Related]
17. Microbiome-Metabolomics Analysis of the Impacts of
Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
[TBL] [Abstract][Full Text] [Related]
18. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.
Maruyama H; Tanaka M; Hashimoto M; Inoue M; Sasahara T
Life Sci; 2007 Jan; 80(8):775-81. PubMed ID: 17157323
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
20. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
